
Lawrence S Zisman MD
Echocardiography, Non-Invasive Cardiology, Clinical Pharmacology
Physician
Join to View Full Profile
Gossamer BioSuite 200San Diego, CA 92121
Phone+1 518-573-8315
Dr. Zisman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Westchester Medical CenterResidency, Internal Medicine, 1987 - 1990
- Albert Einstein College of MedicineClass of 1987
Certifications & Licensure
- CA State Medical License 2019 - 2025
- NY State Medical License 1988 - 2018
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 12 citationsSeralutinib in adults with pulmonary arterial hypertension (TORREY): a randomised, double-blind, placebo-controlled phase 2 trial.Robert P Frantz, Vallerie V McLaughlin, Sandeep Sahay, Pilar Escribano Subías, Ronald L Zolty
The Lancet. Respiratory Medicine. 2024-07-01 - 9 citationsPharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension.Soni Savai Pullamsetti, Ravikumar Sitapara, Robin Osterhout, Astrid Weiss, Laura L Carter
International Journal of Molecular Sciences. 2023-08-10 - 34 citationsInhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension.Anna Galkin, Ravikumar Sitapara, Bryan Clemons, Eduardo Garcia, Michael Kennedy
The European Respiratory Journal. 2022-12-01
Grant Support
- Phosphopeptide Mapping Of Plexiform Lesions In Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2011
- A Pdgfr Inhibitor For The Treatment Of Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2010
- A Novel JAK Inhibitor For The Treatment Of Pulmonary Arterial HypertensionNational Heart, Lung, And Blood Institute2010
- Effect Of Cardiac Tissue Specific Angiotensin Converting Enzyme InhibitionNational Center For Research Resources1998–2000
- Cardiac Renin/Angiotensin System In Heart FailureNational Heart, Lung, And Blood Institute1999
- Cardiac Renin/Angiotensin System In Heart FailureNational Heart, Lung, And Blood Institute1998
- Cardiac Renin/Angiotensin System In Heart FailureNational Heart, Lung, And Blood Institute1995–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: